Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The Fund is designed to be utilized only by knowledgeable investors who understand the potential consequences of seeking daily leveraged (2X) investment results, understand the risks associated with the use of leverage, and are willing to monitor their portfolios frequently
Retatrutide itself is still being evaluated in controlled clinical trial settings, meaning its full safety profile even as a standalone compound has not yet been established
Compounded GLP-1 medications offer effective active ingredients but at a fraction of the price (80% less) and are more consistently available
May be a different drug, a different prescriber
